Skip to main content

Table 3 Distribution of the RIPK1 tag SNPs among cases and controls and their associations with EOC risk

From: RIPK1 polymorphisms and expression levels: impact on genetic susceptibility and clinical outcome of epithelial ovarian cancer

Model

Genotype

rs6907943

Genotype

rs9392453

EOC n (%)

Controls n (%)

OR (95% CI)

P value

EOC n (%)

Controls n (%)

OR (95% CI)

P value

Codominant

AA

168 (52.7%)

186 (49.5%)

1

0.7

TT

179 (56.1%)

249 (66.2%)

1

0.01

AC

123 (38.6%)

155 (41.2%)

0.88 (0.64-1.20)

CT

117 (36.7%)

113 (30.1%)

1.45 (1.04-2)

CC

28 (8.8%)

35 (9.3%)

0.88 (0.52-1.52)

CC

23 (7.2%)

14 (3.7%)

2.27 (1.15-4.55)

Dominant

AA

168 (52.7%)

186 (49.5%)

1

0.4

TT

179 (56.1%)

249 (66.2%)

1

0.006

AC/CC

151 (47.3%)

190 (50.5%)

0.88 (0.65-1.19)

CT/CC

140 (43.9%)

127 (33.8%)

1.54 (1.12-2.08)

Recessive

AA/AC

291 (91.2%)

341 (90.7%)

1

0.8

TT/CT

296 (92.8%)

362 (96.3%)

1

0.042

CC

28 (9.1%)

35 (9.3%)

0.93 (0.56-1.59)

CC

23 (7.2%)

14 (3.7%)

2.00 (1.02-4)

Overdominant

AA/CC

196 (61.4%)

221 (58.8%)

1

0.48

TT/CC

202 (63.3%)

263 (70%)

1

0.07

AC

123 (38.6%)

155 (41.2%)

0.89 (0.66-1.22)

CT

117 (36.7%)

113 (30%)

1.35 (0.98-1.86)

 

Allele

    

Allele

    
 

A

459 (71.5%)

527 (70.1%)

1

0.45

T

475 (74.5%)

611 (81.2%)

1

0.002

C

179 (28.1%)

225 (29.9%)

0.91 (0.72-1.15)

C

163 (25.5%)

141 (18.8%)

1.49 (1.15-1.92)

  1. Bold value Indicates a significant difference at the 5% level